|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Impact of Molecular Medicine on Drug Development | ||||||||||||||||
| November 09, 2001 | ||||||||||||||||
|
German Society for Biochemistry and Molecular Biology (GBM), Mosbach/Baden, Germany 2002-04-05 till 2002-04-07 Impact of Molecular Medicine on Drug Development: Chemical Biology: Challenges for Drug Development Impact of Genomics and Proteomics on Drug Development In Silico Approaches - Model Organisms Pharmacogenomics Gene therapy / therapeutic nucleic acids Discussion panel: stemcells |
||||||||||||||||
| Organized by: | GBM head office, Frankfurt | |||||||||||||||
| Invited Speakers: | R. Baumeister, F. von Bohlen, F. Cambien, T. Carell, P. Cohen, N. Dean, C. Dinarello, J. Drews, G. Duyk, C. Evans, P. Heinrich, D. Horrobin, R.W. King, K. Lindpaintner, U.A. Meyer, C. Nüsslein-Vollhard, D. Santi, H. Waldmann, G. Wess |
|||||||||||||||
| Deadline for Abstracts: | February 1, 2002 | |||||||||||||||
| Registration: | GBM head office, Frankfurt, Germany www.gbm-online.de |
|||||||||||||||
| E-mail: | info@gbm-online.de | |||||||||||||||
| Posted by: | Dr. Jörg Maxton-Küchenmeister | |||||||||||||||
| Host: | hades1-dmz.mpibp-frankfurt.mpg.de | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||